These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12434558

  • 21. Patient characteristics not described.
    Lofsky S.
    CMAJ; 2006 Jun 20; 174(13):1874. PubMed ID: 16785468
    [No Abstract] [Full Text] [Related]

  • 22. A comparative study of the effects of hypoglycemic agents on serum electrolytes in the diabetic patients.
    Javaid A, Hasan R, Zaib A, Mansoor S.
    Pak J Pharm Sci; 2007 Jan 20; 20(1):67-71. PubMed ID: 17337432
    [Abstract] [Full Text] [Related]

  • 23. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar].
    Sidibé EH, Badiane MK, Gueye A.
    Sante; 2002 Jan 20; 12(3):319-22. PubMed ID: 12473527
    [Abstract] [Full Text] [Related]

  • 24. Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus.
    Bokhari SU, Gopal UM, Duckworth WC.
    Am J Med Sci; 2003 Feb 20; 325(2):66-9. PubMed ID: 12589230
    [Abstract] [Full Text] [Related]

  • 25. Metformin decreases platelet superoxide anion production in diabetic patients.
    Gargiulo P, Caccese D, Pignatelli P, Brufani C, De Vito F, Marino R, Lauro R, Violi F, Di Mario U, Sanguigni V.
    Diabetes Metab Res Rev; 2002 Feb 20; 18(2):156-9. PubMed ID: 11994908
    [Abstract] [Full Text] [Related]

  • 26. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
    Torri A, Zanni A, Roncaia R, Di Saverio S.
    Clin Ter; 1977 Jul 15; 82(1):45-56. PubMed ID: 409583
    [No Abstract] [Full Text] [Related]

  • 27. [Metformin in the UKPDS study. Metabolic and vascular results].
    Basin C, Isnard F.
    Journ Annu Diabetol Hotel Dieu; 1999 Jul 15; ():243-61. PubMed ID: 10732421
    [No Abstract] [Full Text] [Related]

  • 28. Fixed dose combination diabetes medicines - usage in the Australian veteran population.
    Gadzhanova S, Gillies M, Roughead E, Zuo Y.
    Aust Fam Physician; 2011 Oct 15; 40(10):811-5. PubMed ID: 22003487
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intensifying type 2 diabetes therapy: assessing the options. Introduction.
    Brunton SA.
    J Fam Pract; 2011 Sep 15; 60(9 Suppl):S3. PubMed ID: 21912772
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Metformin: evidence-based versus rational pharmacotherapy.
    Smits P, Tack CJ.
    Neth J Med; 2002 Jul 15; 60(6):228-30. PubMed ID: 12365465
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.